Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Wyeth-Ayerst licenses Ludwig Institute antibody for anticancer therapy

Nov. 29, 2001

AstraZeneca presents CDK inhibitors in recent patent

Nov. 28, 2001

Pyrrolopyrimidine tyrosine kinase inhibitors claimed by BASF

Nov. 28, 2001

Adenovirus-mediated PTEN gene transfer effective against human colorectal cancer

Nov. 28, 2001

Exelixis delivers further cancer targets to Protein Design Labs

Nov. 28, 2001

RARalpha-selective agonist undergoes early clinical testing in cancer patients

Nov. 28, 2001

OncoGenex and Isis collaborate on antisense drug for prostate and other cancers

Nov. 28, 2001

Active Biotech signs benzamide licensing agreement with Oxigene

Nov. 28, 2001

Antitumor and antimetastatic effects demonstrated in new series from Ishihara Sangyo

Nov. 27, 2001

AstraZeneca to return development rights for ZD-0473 to AnorMED

Nov. 27, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...